Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ocugen, Inc. | CFO/CBO | Common Stock | 166K | $108K | $0.65 | Mar 6, 2023 | Direct |
180 Life Sciences Corp. | COO / Chief Business Officer | Common Stock | 20.5K | $3.85K | $0.19 | Dec 16, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OCGN | Ocugen, Inc. | Mar 6, 2023 | 0 | $0 | 3 | Mar 10, 2023 | CFO/CBO |
ATNF | 180 Life Sciences Corp. | Dec 16, 2021 | 1 | $31.8K | 4 | Dec 16, 2021 | COO / Chief Business Officer |
ATNF | 180 Life Sciences Corp. | Dec 10, 2021 | 1 | $17.6K | 4 | Dec 10, 2021 | COO / Chief Business Officer |
ATNF | 180 Life Sciences Corp. | Dec 8, 2021 | 1 | $0 | 4 | Dec 10, 2021 | COO / Chief Business Officer |
ATNF | 180 Life Sciences Corp. | Oct 29, 2021 | 0 | $0 | 3 | Nov 4, 2021 | COO / Chief Business Officer |